Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B.

Guichan LiaoXia DingMuye XiaYin WuHongjie ChenRong FanXiaoyong ZhangShao-Hang CaiJie Peng

Published in: International journal of general medicine (2021)

Serum EOT HBcrAg level can be a predictor of off-treatment relapse in patients with CHB. An HBcrAg level of 4.0 log10 U/mL may identify patients at high risk of clinical relapse after treatment cessation.

Keyphrases

free survival
bone marrow
mesenchymal stem cells